{"organizations": [], "uuid": "c5383f36d2bfdacd5f3c2d93871ebbf4dc4a6d85", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-teva-announces-launch-of-a-generic/brief-teva-announces-launch-of-a-generic-version-of-syprine-in-the-u-s-idUSASB0C51S", "country": "US", "domain_rank": 408, "title": "BRIEF-Teva Announces Launch Of A Generic Version Of Syprine In The U.S", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-09T16:11:00.000+02:00", "replies_count": 0, "uuid": "c5383f36d2bfdacd5f3c2d93871ebbf4dc4a6d85"}, "author": "", "url": "https://www.reuters.com/article/brief-teva-announces-launch-of-a-generic/brief-teva-announces-launch-of-a-generic-version-of-syprine-in-the-u-s-idUSASB0C51S", "ord_in_thread": 0, "title": "BRIEF-Teva Announces Launch Of A Generic Version Of Syprine In The U.S", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "neutral"}, {"name": "teva", "sentiment": "neutral"}, {"name": "united states", "sentiment": "none"}, {"name": "pharmaceutical industries ltd", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " Teva Announces Launch Of A Generic Version Of Syprine In The U.S Reuters Staff \nFeb 9 (Reuters) - Teva Pharmaceutical Industries Ltd : \n* TEVA ANNOUNCES LAUNCH OF A GENERIC VERSION OF SYPRINE® IN THE UNITED STATES \n* TEVA PHARMACEUTICAL INDUSTRIES LTD - ‍LAUNCH OF GENERIC VERSION OF SYPRINE (TRIENTINE HYDROCHLORIDE) CAPSULES, 250 MG, IN U.S.​ Source text for Eikon:  ", "external_links": [], "published": "2018-02-09T16:11:00.000+02:00", "crawled": "2018-02-09T16:22:35.081+02:00", "highlightTitle": ""}